Company / Profit Margin
ResMed Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
27.2%
FY2025
5-year range
14.8% / 27.2%
FY2021-FY2025
Trend
+24.9%
vs FY2024
Sector context
#4 of 150
Health Care
What the data says
Among 150 Health Care companies, ResMed is in the top 3% for profit margin. Profit Margin has fluctuated over the past 10 years, ranging from 13.5% in FY2018 to 27.2% in FY2025.
Based on SEC 10-K filings.
27.2% in FY2025 with a 5-year CAGR of +6.2%. Top quartile in the Health Care sector.
Improved from 21.3% to 27.2% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +5.4pp
- 5-Year Change
- +6.2pp
- 10-Year Change
- -
Sector benchmark
Top 3% in Health CareTop 3% of 150This company 27.2% Sector average -263.0%
▼
+110.4% above sector average
Key checks
Key Insights
- In FY2025, profit margin increased 24.9% year-over-year.
- Currently 290.2pp above the Health Care sector average.
- Lowest profit margin in the period was in FY2018.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 27.2% | +24.9% |
| FY2024 | 21.8% | +2.5% |
| FY2023 | 21.3% | -2.4% |
| FY2022 | 21.8% | +46.8% |
| FY2021 | 14.8% | -29.4% |
| FY2020 | 21.0% | +35.4% |
| FY2019 | 15.5% | +15.0% |
| FY2018 | 13.5% | -18.5% |
| FY2017 | 16.6% | -13.6% |
| FY2016 | 19.2% | -8.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026